Analysis of Key Market Segments Driving the Menopause Supplement Market

The menopause supplement market is gaining significant traction as awareness around women's health continues to rise. With a growing focus on personalized care and holistic approaches, this sector is poised for remarkable growth in the coming years. Let's explore the market's valuation, major participants, emerging trends, and detailed segmentation to understand its future direction.

Projected Market Valuation of the Menopause Supplement Market by 2030
The menopause supplement market is anticipated to reach a valuation of $2.98 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.7%. This upward trajectory is driven by increasing demand for tailored menopause nutrition, wider adoption of digital platforms focused on women's health, and a stronger emphasis on lifestyle and holistic care approaches. Additionally, the growing distribution of supplements through e-commerce channels, along with increased investments in female health research, are contributing to the market's rapid expansion. Key trends shaping this period include rising interest in natural hormone support, greater use of non-hormonal supplement alternatives, the development of symptom-specific formulations, stronger consumer focus on women-centric wellness products, and a broader acceptance of preventive care for menopause.

Download a free sample of the menopause supplement market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30320&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Players Leading the Menopause Supplement Market
Several major corporations hold a strong presence in the menopause supplement industry. These include Nestlé Health Science, Procter & Gamble, Bayer AG, Church & Dwight* Co. Inc., Herbalife Nutrition Ltd., Amway Corporation, The Nature's Bounty Co., GNC Holdings Inc., Pharmavite LLC, Blackmores Limited, NOW Foods, Thorne HealthTech, Metagenics Inc., Jarrow Formulas Inc., Nature's Way, Vitabiotics Ltd., Standard Process Inc., Swisse Wellness Pty Ltd., Bio-Botanica Inc., and Life Extension.
In a strategic move in June 2025, Hims & Hers Health, Inc., a US-based health and wellness platform focusing on personalized care, acquired UK-based ZAVA. This acquisition aims to expand Hims & Hers' footprint in Europe, leveraging ZAVA's digital platform and medical expertise to provide tailored, high-quality healthcare solutions across various markets. ZAVA specializes in menopause testing and symptom treatment, making it a valuable addition to the portfolio.

Emerging Trends Shaping the Future of Menopause Supplements
Market leaders are increasingly prioritizing innovation by developing personalized supplements that cater to the unique hormonal and nutritional needs of individual women. These customized formulations aim to deliver targeted symptom relief and improve overall effectiveness. Personalized supplements are designed based on factors such as specific health conditions, hormone levels, symptoms, and lifestyle choices.
For example, in September 2025, Desert Harvest, a US-based natural health company, launched its first menopause supplement featuring human-identical lactoferrin. This ingredient closely resembles the form naturally present in the human body, marking a notable breakthrough. The product supports women during peri- and post-menopause by addressing hormonal imbalances, fatigue, and immune health. By combining bioidentical lactoferrin with natural components, Desert Harvest provides a science-backed, non-hormonal alternative for menopause relief and signals its entry into the growing women's health supplement market.

View the full menopause supplement market report:
https://www.thebusinessresearchcompany.com/report/global-menopause-supplement-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Detailed Segmentation of the Menopause Supplement Market
The menopause supplement market is categorized into several segments for a comprehensive understanding:
1) By Product Type: Hormonal supplements, Non-hormonal supplements, Nutritional supplements, and Other products
2) By Form: Tablets, Capsules, Liquids, Powders, gummie*s*, and Soft gels
3) By Gender: Women and Men
4) By Sales Channel: Store-based outlets, Modern trade, Hospital pharmacies, Retail pharmacies, Drug stores, and Online pharmacies
5) By End-user: Hospitals, Homecare, and Clinics

Subcategories include:
- Hormonal Supplements: Estrogen Therapy, Progesterone Therapy, Combined Hormone Therapy, Bioidentical Hormone Therapy
- Non-Hormonal Supplements: Herbal Extract Supplements, Phytoestrogen Supplements, Homeopathic Supplements, Botanical Blend Supplements
- Nutritional Supplements: Vitamin Supplements, Mineral Supplements, Protein Supplements, Omega Fatty Acid Supplements
- Other Products: Probiotic Supplements, Collagen Supplements, Antioxidant Supplements, Enzyme Supplements

This segmentation offers a detailed roadmap for stakeholders seeking to understand consumer preferences and market dynamics within the menopause supplement arena.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.